Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
ES06 - New Approaches in Second Line Treatment In NSCLC
- 13:30 - 15:00
- 9/08/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Susana Cedres, Oliver Gautschi
-
+
ES06.03 - Future Strategies in Second Line Treatment
14:10 - 14:30 | Presenter: Gregory J Riely
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-127 - Antitumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 in NSCLC with EGFR Exon 20 Insertions
09:45 - 09:45 | Presenter: Gregory J Riely | Author(s): Joel W Neal, D. Ross Camidge, Alexander Spira, Zosia Piotrowska, Leora Horn, Daniel B Costa, Anne Tsao, Jyoti D Patel, Shirish Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, HOWARD WEST, Sylvie Vincent, Jian Zhu, Shu Jin, Steven Zhang, Shuanglian Li, Pasi A Jänne
- Abstract
Loading... -
+
P1.01-25 - Real-World Outcomes of Advanced NSCLC Patients with Common and Uncommon/Complex EGFR Mutation Profiles
09:45 - 09:45 | Presenter: Gregory J Riely | Author(s): Christine M Lovly, Carlo G M Messina, Stefanie Bienert, Kimberly Alexander, William Pao, Kelly M Magee, Shrujal S Baxi, Robert C. Doebele
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-39 - Molecular Characteristics, Immunophenotype, and Immune Checkpoint Inhibitor Response in BRAF Non-V600 Mutant Lung Cancers
09:45 - 09:45 | Presenter: Michael Offin | Author(s): Terry Pak, Sebastian Mondaca, Joseph Montecalvo, Natasha Rekhtman, Darragh F Halpenny, Stephanie L Wu, Mark G Kris, Paul Paik, Gregory J Riely, Charles M Rudin, David M. Hyman, Matthew Hellmann, Alexander Drilon, Josiah D Land, Larry Buie, Piro Lito, Rona Yaeger, Dazhi Liu, Bob T Li
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-06 - Tissue-Based Molecular and Histologic Landscape of Acquired Resistance to Osimertinib in Patients with EGFR-Mutant Lung Cancers
09:45 - 09:45 | Presenter: Adam J Schoenfeld | Author(s): Joseph Chan, Hira Rizvi, Romel Somwar, Daisuke Kubota, Yahya Daneshbod, Jason Chang, Michael Offin, Maria E. Arcila, Dana Pe'Er, Mark G Kris, Natasha Rekhtman, Gregory J Riely, Marc Ladanyi, Helena A Yu
- Abstract
Loading... -
+
P1.14-12 - A Novel Activating MAP2K1 In-Frame Deletion Mediates Acquired Resistance to ROS1 TKIs in a Patient with ROS1 Fusion-Positive NSCLC
09:45 - 09:45 | Presenter: Hiroki Sato | Author(s): Adam J Schoenfeld, Evan Siau, Ken Suzawa, Christine Yue, Michael Offin, Alexander Drilon, Monika A Davare, Gregory J Riely, Marc Ladanyi, Romel Somwar
- Abstract
Loading... -
+
P1.14-50 - A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Robin Guo | Author(s): Isabel Preeshagul, Adam J Schoenfeld, Caroline G. McCarthy, Alex Makhnin, Andrew J. Plodkowski, Michelle S. Ginsberg, Monika A Davare, Lukas Delasos, Romel Somwar, Maria E. Arcila, Gregory J Riely, Natasha Rekhtman, Marc Ladanyi, Mark G Kris, Alexander Drilon
- Abstract
Loading...